Inactive Instrument

Analyst Reco. NOVARTIS London S.E.

Equities

End-of-day quote London S.E. Other stock markets
- ^GBX	-

Apr. 24	BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating	MT
Apr. 24	Novartis Says New Malaria Drug Formulation Safe and Effective for Babies	MT

BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating	Apr. 24	MT
NOVARTIS AG : UBS reaffirms its Buy rating	Apr. 24	ZD
NOVARTIS AG : Deutsche Bank gives a Buy rating	Apr. 24	ZD
NOVARTIS AG : JP Morgan remains Neutral	Apr. 24	ZD
NOVARTIS : 2024 has started on a strong note; guidance upgraded	Apr. 23
NOVARTIS AG : JP Morgan gives a Neutral rating	Apr. 23	ZD
NOVARTIS AG : Barclays keeps a Sell rating	Apr. 23	ZD
NOVARTIS : Oddo BHF confirms its recommendation on the share	Apr. 23	CF
NOVARTIS AG : UBS remains its Buy rating	Apr. 23	ZD
NOVARTIS AG : Gets a Buy rating from Jefferies	Apr. 23	ZD
Novartis Raises Guidance on Profit, Sales Growth -- Update	Apr. 23	DJ
Novartis Raises Guidance on Profit, Sales Growth	Apr. 23	DJ
NOVARTIS AG : UBS reiterates its Buy rating	Apr. 18	ZD
NOVARTIS AG : Deutsche Bank maintains a Buy rating	Apr. 18	ZD
Trending : Novartis Begins Tender Offer for MorphoSys Shares	Apr. 11	DJ
NOVARTIS : UBS reiterates its recommendation on the stock	Apr. 11	CF
NOVARTIS AG : UBS remains its Buy rating	Apr. 10	ZD
NOVARTIS AG : Jefferies maintains a Buy rating	Apr. 04	ZD
NOVARTIS AG : UBS reiterates its Buy rating	Apr. 04	ZD
NOVARTIS AG : Gets a Neutral rating from JP Morgan	Apr. 03	ZD